Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...

For the first time in the UK, robotic technology is being used to support genomic testing for cancer patients following a partnership between The Royal Marsden NHS Foundation Trust and Automata ...

(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...

FT. MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading provider of oncology testing services, today announced the acquisition of Pathline, LLC, a ...

Targeted Genomics LLC on Wednesday announced a commercial collaboration with OraSure Technologies (NASDAQ:OSUR) which manufactures ORAcollect·Dx, a saliva collection device approved for general ...

Aurora-based Children’s Hospital Colorado has opened an in-house genomics testing lab through its Precision Medicine Institute. The lab enables genomic testing results to be more quickly integrated ...

Metropolis Healthcare has launched a Centre for Genomics to expand its specialty diagnostics business. The company plans to ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...